Opinions
Jon Nagerian, Co-founder, MarketRebellion.com
Iovance Biotherapeutics
IOVA-Q
BUY
Mar 23, 2022
A biopharma in the cancer space. Shares are jumping today. The market is buying big upside calls $10 higher than current share prices. They may release good news at one of the upcoming medical conferences.
$16.520
Stock price when the opinion was issued
biotechnology
pharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
Advertising